期刊文献+

PTENIVS4基因多态性与子宫内膜息肉及子宫内膜癌风险的相关性 被引量:1

Correlation between PTEN IVS4 polymorphism and the risk of endometrial polyps and endometrial cancer
下载PDF
导出
摘要 目的 探讨PTEN IVS4基因多态性(rs 3830675)与子宫内膜息肉及子宫内膜癌风险的关系.方法 本研究是以中国汉族人群为研究对象的病例对照研究,选取150例子宫内膜息肉患者为病例组,100例年龄相匹配的健康女性为对照组.应用聚合酶链反应-限制性片段长度多态性PCR-RFLP分析方法对单核苷酸多态性(r3830675)进行基因分型.结果 对照组、子宫内膜息肉组和子宫内膜癌组年龄、体质量指数、初产年龄、产次、吸烟及饮酒分布均无统计学差异(P>0.05).PTENIVS4基因型和等位基因分布在病例组和对照组中无统计学差异(χ2=0.996,df=2,P=0.608;χ2=0.651,df=1,P=0.420).病例组与对照组携带(-/+)、(+/+)基因型与(-/-)基因型相比发生子宫内膜息肉的风险无统计学差异(OR=0.864,95% CI:0.505~1.478,P=0.593;OR=0.770,95% CI:0.452-1.312,P=0.337).携带等位基因[-]与等位基因[+]相比发生子宫内膜息肉的风险也没有显著差异(OR=0.857,95%CI:0.589~1.247,P=0.420).在病例组中,携带(-/+)基因型较(-/-)基因型发生子宫内膜癌风险显著降低(OR=0.433,95% CI:0.207~ 0.908,P=0.027),等位基因[+]较等位基因[-]发生子宫内膜癌风险显著降低(OR=0.542,95%CI:0.305~ 0.962,P=0.036).结论 PTEN IVS4多态性可能是子宫内膜息肉恶化的危险因素. Objective To explore the relationship between polymorphism (rs 3830675) in the PTEN and the risk of endometrial polyps and endometrial cancer. Methods In a hospital case-control study for the Chinese population in China, 150 patients with endometrial polyps and 100 sex matched healthy subjects were enrolled in this study. Polymorphism was genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RLFP) technique. Results There were no statistical differences in age, body mass index, primiparity age, parity, distribution of smoking and alcohol drinking between control group, cases with endometrial polyps group and cases with endometrial cancer group. No statistically significant differences were found in the genotypic distribution and allele frequency of PTEN IVS4 between the case and control subjects (χ 2=0.996, df=-2, P=0.608; χ2=0.651, df=1, P=0.420), in the risk of endometrial polyps associated with (-/-) genotype compared with the (+/-) and (+/+) genotype (OR=0.864, 95% CI: 0.505-1.478, P=0.593; OR=0.770, 95% CI: 0.452-1.312, P=0.337), or in the risk of endometrial polyps associated with allele [-] and allele [+] (OR=0.857, 95% CI: 0.589-1.247, P=0.420). In the cases with endometrial polyps, a significantly decreased risk of endometrial cancer associated with (+/-) genotype (OR=0.433, 95% CI: 0.207-0.908, P=0.027) was detected compared with the (-/-) genotype. Compared with the individual carrying allele [-], the risk of endometrial cancer with allele [+] decreased (OR=0.542, 95% CI: 0.305-0.962, P=0.036). Conclusion PTEN IVS4 polymorphism (rs 3830675) may be a risk factor of endometrial polyps progression.
出处 《解放军医学院学报》 CAS 2014年第9期957-960,共4页 Academic Journal of Chinese PLA Medical School
关键词 PTENIVS4 多态性 子宫内膜息肉 PTEN IVS4 polymorphism endometrial polyps
  • 相关文献

参考文献16

  • 1Lasmar BP,Lasmar RB.Endometrial polyp size and polyp hyperplasia[J].Int J Gynaecol Obstet,2013,123 (3):236-239.
  • 2Lieng M,Istre O,Sandvik L,et al.Prevalence,l-year regression rate,and clinical significance of asymptomatic endometrial polyps:cross-sectional study[J].J Minim Invasive Gynecol,2009,16(4):465-471.
  • 3Cho H J,Lee ES,Lee JY,et al.Investigations for postmenopausal uterine bleeding:special considerations for endometrial volume[J].Arch Iran Med,2013,16 (11):665-670.
  • 4Costa-Paiva L,Antunes Junior A,Pinto-Neto AM.Current management in endometrial polyps[J].Rev Bras Ginecol Obstet,2013,35 (4):143-145.
  • 5Zhang HY,Liang F,Jia ZL,et al.PTEN mutation,methylation and expression in breast Cancer patients[J].Oncol Lett,2013,6 (1):161-168.
  • 6Campos EC,Fonseca FP,Zequ SD,et al.Analysis of PTEN gene by fluorescent in situ hybridization in renal cell carcinoma[J].Rev Col Bras Cir,2013,40 (6):471-475.
  • 7Hong X,Song R,Song H,et al.PTEN antagonises Tcl1/ hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis[J/OL].http://gut.bmj.com/content/early/2013/12/18/gutj nl-2013-305302.long.
  • 8Simpson L,Parsons R.PTEN:Life as a tumor suppressor[J].Exp Cell Res,2001,264 (1):29-41.
  • 9Canbay E,Kahraman OT,Bugra D,et al.Association between PTEN IVS4 polymorphism and development of colorectal Cancer in a Turkish population[J].Expert Opin Ther Targets,2013,17 (1):1-6.
  • 10Ozturk O,Canbay E,Kahraman OT,et al.HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast Cancer[J].Mol Biol Rep,2013,40 (2):1813-1818.

二级参考文献15

  • 1Morice P,Castaigne D. Advances in the surgical management of invasive cervical Cancer[J].{H}Current Opinion in Obstetrics & Gynecology,2005,(01):5-12.
  • 2Dursun P,LeBlanc E,Nogueira MC. Radical vaginal trachelectomy (Dargent's operation):a critical review of the literature[J].{H}EUROPEAN JOURNAL OF SURGICAL ONCOLOGY,2007,(08):933-941.
  • 3中华人民共和国卫生部.2010中国卫生统计年鉴.
  • 4Neto AS,Tobias-Machado M,Wroclawski ML. Molecular oncogenesis of prostate adenocarcinoma:role of the human epidermal growth factor receptor 2(HER-2/neu)[J].{H}TUMORI,2010,(05):645-649.
  • 5Pintens S,Neven P,Drijkoningen M. Triple negative breast cancer:a study from the point of view of basal CK5/6 and HER-1[J].{H}Journal of Clinical Pathology,2009,(07):624-628.
  • 6Leibl S,Bodo K,Gogg-Kammerer M. Ovarian granulosa cell tumors frequently Express EGFR(Her-1),Her-3,and Her-4:An immunohistochemical study[J].{H}Gynecologic Oncology,2006,(01):18-23.
  • 7Witton CJ,Reeves JR,Going JJ. Expression of the HER1-4 family of receptor tyrosine kinases in breast Cancer[J].{H}Journal of Pathology,2003,(03):290-297.
  • 8Kountourakis P,Pavlakis K,Psyrri A. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas[J].{H}BMC Cancer,2006.46.
  • 9Ross JS,Slodkowska EA,Symmans WF. The HER-2 receptor and breast Cancer:ten years of targeted anti-HER-2 therapy and personalized medicine[J].{H}Oncologist(the)t,2009,(04):320-368.
  • 10Bahnassi AA,Zekri AR,El-Houssini S. Hepatitis C virus-NS3P in relation to p53,p21waf,mdm2,p21-ras and c-erbB2 in hepatocarcinogenesis[J].{H}Gastroenterologia y Hepatologia,2005,(11):1731-1740.

共引文献2

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部